NCT01990625

Brief Summary

In many low-income countries, the use of ultrasound by medical officers and non-physician health care staff (e.g., midwives) for antenatal identification of high risk pregnancies is a new intervention requiring authoritative investigation. The primary hypothesis to be assessed in this study is that antenatal ultrasound screenings performed by medical officers and non-physician health care staff will significantly reduce a composite outcome consisting of maternal mortality and maternal near miss, stillbirth and neonatal mortality in low-resource settings. Underpinning this hypothesis are two assumptions. The first assumption is that antenatal detection of complicated pregnancies will lead to appropriate referral at the right time for complicated pregnancies to comprehensive emergency obstetric and neonatal care (EmONC) facilities. The second assumption is that ultrasound's introduction will increase antenatal attendance leading to greater rates of institutional delivery. To assess these underlying assumptions beyond the composite end point, this study will investigate the health system impact of compact ultrasound. Secondary outcomes include antenatal attendance rates, institutional delivery rates at basic EmONC facilities, referral rates to comprehensive EmONC facilities, cesarean section rates (both planned and emergent) and an assessment of medical officers and non-physician health care provider ultrasound competence and training quality.

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45,038

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
Completed

Started Apr 2014

Typical duration for not_applicable pregnancy

Geographic Reach
5 countries

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

September 29, 2016

Status Verified

September 1, 2016

Enrollment Period

2.3 years

First QC Date

November 15, 2013

Last Update Submit

September 27, 2016

Conditions

Keywords

Maternal Near Miss MorbidityMaternal MortalityNeonatal MortalityGestational Age DatingPregnancy ComplicationsUltrasoundStillbirth

Outcome Measures

Primary Outcomes (1)

  • Composite outcome

    Introduction of ultrasound will decrease the composite outcome of maternal mortality and near miss maternal mortality events and stillbirths plus early neonatal mortality.

    Up to 30 months

Secondary Outcomes (1)

  • Rate of Women with Complicated Deliveries at Health Facilities

    Up to 30 months

Other Outcomes (1)

  • Antenatal Care Utilization

    Up to 30 months

Study Arms (2)

Ultrasound scan

EXPERIMENTAL

The group is pregnant women who reside in an intervention cluster who receive at least one antenatal ultrasound scan during antenatal care during the study time period.

Device: Antenatal Ultrasound Scan

Routine antenatal care

NO INTERVENTION

The group is pregnant women that reside in the control clusters during the study time period. The group received routine antenatal care.

Interventions

Women in the intervention arm will be provided two ultrasound scans to screen for pregnancy complications.

Ultrasound scan

Eligibility Criteria

Age12 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women who provide consent
  • Resident of study cluster
  • Enrolled/eligible for the Global Network Maternal and Neonatal Health Registry
  • Women \>16 weeks gestation at enrollment

You may not qualify if:

  • \- Women who are in labor at time of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

IMSALUD / San Carlos University

Guatemala City, Guatemala

Location

Moi University School of Medicine

Eldoret, 30100, Kenya

Location

The Aga Khan University

Karachi, Pakistan

Location

Kinshasa School of Public Health

Gemena, Equateur, Republic of the Congo

Location

University Teaching Hospital

Lusaka, Zambia

Location

Related Publications (6)

  • Nathan R, Swanson JO, Marks W, Goldsmith N, Vance C, Sserwanga NB, Swanson D, McClure EM, Franklin H, Mirza W, Mwenechanya M, Muyodi D, Figuero L, Bolamba VL, Goldenberg RL, Pineda IS. Screening obstetric ultrasound training for a 5-country cluster randomized controlled trial. Ultrasound Q. 2014 Dec;30(4):262-6. doi: 10.1097/RUQ.0000000000000096.

    PMID: 25415862BACKGROUND
  • McClure EM, Nathan RO, Saleem S, Esamai F, Garces A, Chomba E, Tshefu A, Swanson D, Mabeya H, Figuero L, Mirza W, Muyodi D, Franklin H, Lokangaka A, Bidashimwa D, Pasha O, Mwenechanya M, Bose CL, Carlo WA, Hambidge KM, Liechty EA, Krebs N, Wallace DD, Swanson J, Koso-Thomas M, Widmer R, Goldenberg RL. First look: a cluster-randomized trial of ultrasound to improve pregnancy outcomes in low income country settings. BMC Pregnancy Childbirth. 2014 Feb 17;14:73. doi: 10.1186/1471-2393-14-73.

    PMID: 24533878BACKGROUND
  • Bresnahan BW, Vodicka E, Babigumira JB, Malik AM, Yego F, Lokangaka A, Chitah BM, Bauer Z, Chavez H, Moore JL, Garrison LP, Swanson JO, Swanson D, McClure EM, Goldenberg RL, Esamai F, Garces AL, Chomba E, Saleem S, Tshefu A, Bose CL, Bauserman M, Carlo W, Bucher S, Liechty EA, Nathan RO. Cost estimation alongside a multi-regional, multi-country randomized trial of antenatal ultrasound in five low-and-middle-income countries. BMC Public Health. 2021 May 20;21(1):952. doi: 10.1186/s12889-021-10750-8.

  • Figueroa L, McClure EM, Swanson J, Nathan R, Garces AL, Moore JL, Krebs NF, Hambidge KM, Bauserman M, Lokangaka A, Tshefu A, Mirza W, Saleem S, Naqvi F, Carlo WA, Chomba E, Liechty EA, Esamai F, Swanson D, Bose CL, Goldenberg RL. Oligohydramnios: a prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. Reprod Health. 2020 Jan 30;17(1):19. doi: 10.1186/s12978-020-0854-y.

  • Bauserman M, Nathan R, Lokangaka A, McClure EM, Moore J, Ishoso D, Tshefu A, Figueroa L, Garces A, Harrison MS, Wallace D, Saleem S, Mirza W, Krebs N, Hambidge M, Carlo W, Chomba E, Miodovnik M, Koso-Thomas M, Liechty EA, Esamai F, Swanson J, Swanson D, Goldenberg RL, Bose C. Polyhydramnios among women in a cluster-randomized trial of ultrasound during prenatal care within five low and low-middle income countries: a secondary analysis of the first look study. BMC Pregnancy Childbirth. 2019 Jul 22;19(1):258. doi: 10.1186/s12884-019-2412-6.

  • Franklin HL, Mirza W, Swanson DL, Newman JE, Goldenberg RL, Muyodi D, Figueroa L, Nathan RO, Swanson JO, Goldsmith N, Kanaiza N, Naqvi F, Pineda IS, Lopez-Gomez W, Hamsumonde D, Bolamba VL, Fogleman EV, Saleem S, Esamai F, Liechty EA, Garces AL, Krebs NF, Michael Hambidge K, Chomba E, Mwenechanya M, Carlo WA, Tshefu A, Lokangaka A, Bose CL, Koso-Thomas M, Miodovnik M, McClure EM. Factors influencing referrals for ultrasound-diagnosed complications during prenatal care in five low and middle income countries. Reprod Health. 2018 Dec 12;15(1):204. doi: 10.1186/s12978-018-0647-8.

MeSH Terms

Conditions

EclampsiaPlacenta PreviaStillbirthFetal Growth RetardationMaternal DeathPregnancy Complications

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesObstetric Labor ComplicationsPlacenta DiseasesFetal DeathDeathPathologic ProcessesPathological Conditions, Signs and SymptomsFetal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersParental Death

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2013

First Posted

November 21, 2013

Study Start

April 1, 2014

Primary Completion

August 1, 2016

Study Completion

September 1, 2016

Last Updated

September 29, 2016

Record last verified: 2016-09

Locations